China Microbiota Transplantation System

FMT Medical is a pioneering biotechnology company based in Nanjing, China, that focuses on the standardization and clinical application of fecal microbiota transplantation (FMT). The company is the primary developer of the China Microbiota Transplantation System (CMTS), a comprehensive platform designed to manage donor screening, microbiota purification, and clinical data for FMT procedures nationwide. Their flagship technology, the GenFMTer, is an automated purification system that enables Washed Microbiota Transplantation (WMT), a method that significantly reduces the risk of adverse events by removing pro-inflammatory factors from donor samples. FMT Medical's products and protocols are utilized by hundreds of medical institutions across China to treat a variety of conditions, including refractory gastrointestinal infections and inflammatory bowel diseases. The company also operates the China Microbiota Bank (CMB), ensuring a high-quality and traceable supply of therapeutic microbiota. Through its integrated approach, FMT Medical aims to transform FMT from a traditional procedure into a modern, standardized, and evidence-based medical therapy.